Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

IDEXX LABORATORIES, INC.

(IDXX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/20/2021 09/21/2021 09/22/2021 09/23/2021 09/24/2021 Date
659.78(c) 666.87(c) 671.47(c) 682.58(c) 679.64(c) Last
725 184 739 149 320 147 369 926 196 409 Volume
-0.29% +1.07% +0.69% +1.65% -0.43% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 3 196 M - -
Net income 2021 721 M - -
Net Debt 2021 403 M - -
P/E ratio 2021 81,6x
Yield 2021 -
Sales 2022 3 542 M - -
Net income 2022 796 M - -
Net Debt 2022 128 M - -
P/E ratio 2022 73,4x
Yield 2022 -
Capitalization 57 821 M 57 821 M -
EV / Sales 2021 18,2x
EV / Sales 2022 16,4x
Nbr of Employees 9 300
Free-Float 79,0%
More Financials
Company
IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. The Company also sells a line of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. Its segments include diagnostic and information technology-based products and services for the... 
More about the company
Ratings of IDEXX Laboratories, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about IDEXX LABORATORIES, INC.
09/23Ocular therapeutix appoints merilee raines to its board of directors
AQ
08/18IDEXX LABORATORIES : Insider Sale at IDEXX Laboratories (IDXX) Continues Selling Trend
MT
08/17INSIDER TRENDS : Insider 90-Day Selling Trend Extended at IDEXX Laboratories
MT
08/13IDEXX LABORATORIES : Credit Suisse Adjusts IDEXX Laboratories' PT to $770 From $735 on Dou..
MT
08/10IDEXX LABORATORIES : Significant Insider Selling in Shares of IDEXX Laboratories (IDXX) Co..
MT
08/09INSIDER TRENDS : IDEXX Laboratories Insider Extends 90-Day Selling Trend
MT
08/09IDEXX LABORATORIES : to Host Virtual Investor Day
PR
08/03IDEXX LABORATORIES : Goldman Sachs Adjusts IDEXX Laboratories' Price Target to $610 from $..
MT
08/02IDEXX LABORATORIES : Barclays Adjusts IDEXX Laboratories' Price Target to $750 From $616, ..
MT
07/30IDEXX LABORATORIES : DE Management's Discussion and Analysis of Financial Condition and Re..
AQ
07/30Tranche Update on IDEXX Laboratories, Inc.'s Equity Buyback Plan announced on August 13..
CI
07/30IDEXX LABORATORIES : Announces Second Quarter Results (Form 8-K)
PU
07/30IDEXX LABORATORIES : Posts Higher Q2 Profit, Revenue; Lifts 2021 Outlook
MT
07/30IDEXX : Q2 Earnings Snapshot
AQ
07/30IDEXX LABORATORIES INC /DE : Results of Operations and Financial Condition, Financial Stat..
AQ
More news
News in other languages on IDEXX LABORATORIES, INC.
09/01Wall Street : finit en roue libre un mois d'août exceptionnel
08/31Wall Street : finit en roue libre un mois d'août exceptionnel
08/18La vente d'initié chez IDEXX Laboratories (IDXX) poursuit la tendance à la vente
08/02Wall Street : juillet positif de +2,3%, repli hebdo de -0,35%
07/30Wall Street : juillet positif de +2,3%, repli hebdo de -0,35%
More news
Analyst Recommendations on IDEXX LABORATORIES, INC.
More recommendations
Stock Trading Strategies
IDEXX LABORATORIES, INC. - 2020
Technically solid
BUY
More Stock Trading Analysis
Chart IDEXX LABORATORIES, INC.
Duration : Period :
IDEXX Laboratories, Inc. Technical Analysis Chart | IDXX | US45168D1046 | MarketScreener
Technical analysis trends IDEXX LABORATORIES, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Last Close Price 679,64 $
Average target price 658,00 $
Spread / Average Target -3,18%
EPS Revisions
Managers and Directors
Jonathan J. Mazelsky President, Chief Executive Officer & Director
Brian Patrick McKeon Chief Financial Officer, Treasurer & Executive VP
Lawrence D. Kingsley Non-Executive Chairman
Ken Grady Chief Information Officer & Senior VP
Jeffrey Thomas Chief Technology Officer & Senior VP
Sector and Competitors
1st jan.Capi. (M$)
IDEXX LABORATORIES, INC.35.96%57 821
ABBOTT LABORATORIES13.59%220 485
MEDTRONIC PLC11.00%174 982
STRYKER CORPORATION12.90%104 320
BECTON, DICKINSON AND COMPANY1.18%72 711
HOYA CORPORATION30.69%62 143